Australas J Dermatol. 2006 May;47(2):84-9.

 

Recent developments in the treatment of adult atopic dermatitis.

 

Pua VS, Barnetson RS.

 

Department of Dermatology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.

 

Atopic dermatitis is a common inflammatory skin condition with increasing incidence in recent decades. The mainstay of treatment has been the combination of emollients and topical corticosteroids, with the addition of systemic therapies in severe cases. New drugs such as the topical calcineurin inhibitors have shown promise in treating mild-to-severe atopic dermatitis. Other novel therapies that have been reported in the literature include leukotriene antagonists, monoclonal antibodies such as infliximab, leflunomide, recombinant interferon gamma and intravenous immunoglobulin. This review will focus on the treatment of adult atopic dermatitis.

 

Publication Types:
Review

 

PMID: 16637800 [PubMed - indexed for MEDLINE]


Full Article Available Online

 


 

Please Review The Environmental Illness Resource on Google or FacebookPlease Help Support EiR with a Positive Google or Facebook Page Review!

If you like EiR and / or enoyed this content; please help us keep going by leaving a Positive Google Review:

https://g.page/r/CbAgn_56aqWaEAI/review 

OR:

Facebook: https://www.facebook.com/ei.resource

P.S. This is entirely secure, we collect no data other than what is freely available from Google and you can remain anonymous!

 


Related Articles:

 

Mold Testing & Sanitizer:

 

 

 

 

ADVERTISEMENT